MedPath

Akorn Operating Company LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Buprenorphine and Naloxone

Approval Date
Dec 20, 2023
FDA

buprenorphine hydrochloride

Approval Date
Dec 20, 2023
FDA

Myorisan

Approval Date
Dec 19, 2022
FDA

Cimetidine Hydrochloride Oral Solution

Approval Date
Oct 17, 2022
FDA

Sulfamethoxazole and Trimethoprim

Approval Date
Oct 14, 2022
FDA

hydrocortisone and acetic acid

Approval Date
Oct 13, 2022
FDA

Aminocaproic Acid

Approval Date
Jul 6, 2022
FDA

AMICAR

Approval Date
Jun 28, 2022
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.